<DOC>
	<DOC>NCT01106807</DOC>
	<brief_summary>The purpose of the study is to evaluate the efficacy of CD07223 1.5% Gel and 0.5% gel in reducing inflammatory, non-inflammatory, and total acne lesion counts after 6 weeks of twice daily applications. The study will also evaluate the safety of the study products using tolerance and adverse event data.</brief_summary>
	<brief_title>Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne</brief_title>
	<detailed_description />
	<mesh_term>Adapalene, Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>subject has a clinical diagnosis of acne vulgaris with facial involvement the subject has at least 15 inflammatory lesions and 25 noninflammatory lesions (excluding the nose) but no more than 2 nodules on the face subject has a severe acne form or secondary acne form the number of inflammatory or noninflammatory lesions on one halfface is greater than twice the number on the other halfface the subject has a known allergy or sensitivity to any of the components of the study products subject is not willing to respect washout periods for topical and/or systemic treatments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>